会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Pyrrolobenzimidazoles, pharmaceutical compositions containing them and
method of using them to treat certain heart and circulatory diseases
    • 吡咯并苯并咪唑,含有它们的药物组合物和使用它们治疗某些心脏和循环系统疾病的方法
    • US4695567A
    • 1987-09-22
    • US820259
    • 1986-01-17
    • Alfred MertensJens-Peter HolckHerbert BergerBernd Muller-BeckmannKlaus StreinEgon Roesch
    • Alfred MertensJens-Peter HolckHerbert BergerBernd Muller-BeckmannKlaus StreinEgon Roesch
    • A61K31/415A61K31/4184A61K31/42A61K31/50A61K31/505A61P9/00A61P9/04C07D403/12C07D405/12C07D487/04C07D403/06
    • C07D403/12C07D405/12C07D487/04
    • The present invention provided pyrrolobenzimidazoles or tautomer thereof, of the general formula: ##STR1## wherein R.sub.1 is hydrogen, C.sub.1 -C.sub.6 alkyl, C.sub.2 -C.sub.6 alkenyl or C.sub.3 -C.sub.7 cycloalkyl;R.sub.2 is hydrogen, cyano, C.sub.1 -C.sub.6 alkyl, C.sub.2 -C.sub.6 alkenyl, or a carbonyl group substituted by hydroxyl, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkyoxy, amino, C.sub.1 -C.sub.6 alkylamino, C.sub.2 -C.sub.12 dialkylamino or hydrazino, orR.sub.2 and R.sub.1 together with the carbon to which they are attached form a C.sub.3 -C.sub.8 spirocycloalkyl ring, or R.sub.1 and R.sub.2 together form C.sub.3 -C.sub.7 alkylidene or C.sub.3 -C.sub.7 cycloalkylkidene,X is a valency bond, C.sub.1 -C.sub.4 alkylene or vinylene andT is oxygen or sulphur;and Het is furanyl, thienyl, pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, thiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, pyrazinyl, pyrimidinyl or pyridazinyl wherein the heterocyclic five- and six-membered rings are unsubstituted or substituted by one or more C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy, C.sub.1 -C.sub.6 alkylthio, hydroxyl, oxo, nitro, amino, halo, carboxyl, C.sub.2 -C.sub.7 alkoxycarbonyl, aminocarbonyl or cyano groups; or a physiologically acceptable salt thereof with an inorganic or organic acid. These compounds are useful for treating heart or circulatory diseases, especially those which respond to a change of blood pressure, an increase in cardiac output and/or a change in micro-circulation.
    • 本发明提供了以下通式的吡咯并苯并咪唑或其互变异构体:其中R 1是氢,C 1 -C 6烷基,C 2 -C 6烯基或C 3 -C 7环烷基; R2是氢,氰基,C1-C6烷基,C2-C6烯基或被羟基,C1-C6烷基,C1-C6烷氧基,氨基,C1-C6烷基氨基,C2-C12二烷基氨基或肼基取代的羰基或R2 并且R 1与它们所连接的碳一起形成C 3 -C 8螺环烷基环,或者R 1和R 2一起形成C 3 -C 7亚烷基或C 3 -C 7环烷基,X是价键,C 1 -C 4亚烷基或亚乙烯基,T是 氧或硫; 并且Het是呋喃基,噻吩基,吡咯基,吡唑基,咪唑基,恶唑基,噻唑基,三唑基,恶二唑基,噻二唑基,吡嗪基,嘧啶基或哒嗪基,其中杂环五元和六元环是未取代的或被一个或多个C 1 -C 6烷基 C 1 -C 6烷氧基,C 1 -C 6烷硫基,羟基,氧代,硝基,氨基,卤素,羧基,C 2 -C 7烷氧基羰基,氨基羰基或氰基; 或其生理上可接受的盐与无机或有机酸反应。 这些化合物可用于治疗心脏或循环系统疾病,特别是那些响应血压变化,心输出量增加和/或微循环变化的化合物。
    • 5. 发明授权
    • N-Substituted aziridine-2-carboxylic acid derivatives for immuno
stimulation
    • N-取代的氮丙啶-2-羧酸衍生物用于免疫刺激
    • US4321194A
    • 1982-03-23
    • US59863
    • 1979-07-23
    • Elmar BosiesHerbert BergerWolfgang KampeUwe BickerAlfred Grafe
    • Elmar BosiesHerbert BergerWolfgang KampeUwe BickerAlfred Grafe
    • C07D203/08A61K31/395A61K31/396A61K31/40A61K31/44A61K31/4427A61K31/443A61K31/4433A61P37/04C07D203/06C07D401/04C07D403/06C07D405/04C07D409/04C07D203/10C07D203/12C07D203/14
    • C07D203/06Y10S514/885
    • Aziridine-2-carboxylic acid derivatives of the formula ##STR1## wherein X is a carboxyl, nitrile, alkoxycarbonyl or carbamoyl group, andR and R.sup.1 are various organic radicals, or pharmacologically acceptable salts thereof, exhibit marked immunostimulant activity, especially in conjunction with added chemotherapeutic agents such as a penicillin, a cephalosporin, a nitrofuran or chloramphenicol. Those compounds are new where X is a cyano group or an alkoxycarbonyl radical and R.sub.1 is a hydrogen atom, but R' is not an unsubstituted alkyl radical or an alkyl radical substituted by hydroxyl, alkoxy, dialkylamino, phenyl, 4-chlorophenyl or 4-methoxyphenyl or a vinyl radical substituted by a phenyl or methyl radical, or a cycloalkyl radical, a phenyl a 4-chlorophenyl, a 4-methoxyphenyl, an s-triazinyl or a pyridinyl radical; or where X is a carbamoyl group and R.sub.1 is a hydrogen atom, R' is not an unsubstituted cyclohexyl, alkyl or benzyl radical; or where X is a cyano group or an alkoxycarbonyl radical and R.sub.1 is a phenyl radical, R' is not an isopropyl, cyclohexyl, phenyl, benzyl or p-chlorobenzyl radical; or where R.sub.1 is a methyl radical, R.sup.1 is not a benzyl, p-chloro- or p- methoxybenzyl radical.
    • 其中X是羧基,腈,烷氧基羰基或氨基甲酰基的氮杂环丁烷-2-羧酸衍生物,R和R 1是各种有机基团或其药理学上可接受的盐,具有显着的免疫刺激活性,特别是与 添加化学治疗剂如青霉素,头孢菌素,硝基呋喃或氯霉素。 那些化合物是新的,其中X是氰基或烷氧基羰基,R 1是氢原子,但R'不是未取代的烷基或被羟基,烷氧基,二烷基氨基,苯基,4-氯苯基或4- 甲氧基苯基或被苯基或甲基取代的乙烯基,或环烷基,苯基,4-氯苯基,4-甲氧基苯基,s-三嗪基或吡啶基; 或其中X为氨基甲酰基,R 1为氢原子,R'为未取代的环己基,烷基或苄基; 或其中X为氰基或烷氧基羰基,R 1为苯基,R'不为异丙基,环己基,苯基,苄基或对氯苄基; 或其中R 1是甲基,R 1不是苄基,对氯或对甲氧基苄基。
    • 10. 发明授权
    • N-Substituted aziridine-2-carboxylic acid derivatives and
immuno-stimulation composition and method
    • N-取代的氮丙啶-2-羧酸衍生物和免疫刺激组合物和方法
    • US4409236A
    • 1983-10-11
    • US268964
    • 1981-06-01
    • Elmar BosiesHerbert BergerWolfgang KampeUwe BickerAlfred Grafe
    • Elmar BosiesHerbert BergerWolfgang KampeUwe BickerAlfred Grafe
    • C07D203/08A61K31/395A61K31/396A61K31/40A61K31/44A61K31/4427A61K31/443A61K31/4433A61P37/04C07D203/06C07D401/04C07D403/06C07D405/04C07D409/04C07D333/30
    • C07D203/06Y10S514/885
    • Aziridine-2-carboxylic acid derivatives of the formula ##STR1## wherein X is a carboxyl, nitrile, alkoxycarbonyl or carbamoyl group, andR and R.sup.1 are various organic radicals; or pharmacologically acceptable salts thereof, exhibit marked immunostimulant activity, especially in conjunction with added chemotherapeutic agents such as a penicillin, a cephalosporin, a nitrofuran or chloramphenicol. Those compounds are new where X is a cyano group or an alkoxycarbonyl radical and R.sub.1 is a hydrogen atom, but R' is not an unsubstituted alkyl radical or an alkyl radical substituted by hydroxyl, alkoxy, dialkylamino, phenyl, 4-chlorophenyl or 4-methoxyphenyl or a vinyl radical substituted by a phenyl or methyl radical, or a cycloalkyl radical, a phenyl, a 4-chlorophenyl, a 4-methoxyphenyl, an s-triazinyl or a pyridinyl radical; or where X is a carbamoyl group and R.sub.1 is a hydrogen atom, R' is not an unsubstituted cyclohexyl, alkyl or benzyl radical; or where X is a cyano group or an alkoxycarbonyl radical and R.sub.1 is a phenyl radical, R' is not an isopropyl, cyclohexyl, phenyl, benzyl or p-chlorobenzyl radical; or where R.sub.1 is a methyl radical, R.sup.1 is not a benzyl, p-chloro- or p- methoxybenzyl radical.
    • 其中X是羧基,腈,烷氧基羰基或氨基甲酰基,R和R 1是各种有机基团; 或其药理学上可接受的盐具有显着的免疫刺激活性,特别是与添加的化学治疗剂如青霉素,头孢菌素,硝基呋喃或氯霉素结合使用。 那些化合物是新的,其中X是氰基或烷氧基羰基,R 1是氢原子,但R'不是未取代的烷基或被羟基,烷氧基,二烷基氨基,苯基,4-氯苯基或4- 甲氧基苯基或被苯基或甲基取代的乙烯基,或环烷基,苯基,4-氯苯基,4-甲氧基苯基,s-三嗪基或吡啶基; 或其中X为氨基甲酰基,R 1为氢原子,R'为未取代的环己基,烷基或苄基; 或其中X为氰基或烷氧基羰基,R 1为苯基,R'不为异丙基,环己基,苯基,苄基或对氯苄基; 或其中R 1是甲基,R 1不是苄基,对氯或对甲氧基苄基。